2025 third_quarter Filing
Q3Income
$50K
Filed
October 20, 2025
Lobbying Activities
PharmacyView all
Issues related to prescription drug pricing. Biosimilar Red Tape Elimination Act. S. 1095 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. Ensuring Timely Access to Generics Act. S. 1032/H.R. 1843 Increasing Transparency in Generic Drug Applications Act. S. 2630, Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Medicare/MedicaidView all
Issues related to prescription drug prices. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S.229 DTC Act of 2025. Issues related to H.R. 1, One Big Beautiful Bill Act.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (3)
MARTIN WHITMER
Deputy CoS-USDOT
THOMAS WORRALL
ERIK KOMENDANT
Legislative Correspondent, Rep. Zoe Lofgren (CA); Legislative Director, Rep. Jason Altmire (PA); Policy Director, Blue Dog Coalition